CoQ10 may reduce postoperative inflammation

The most common kind of liver cancer in men and women over 50 typically comes from long term damage and scarring due to chronic inflammation, high levels of oxidative stress, excess alcohol, autoimmune disease, viral infection, or iron overload.

In the first study to promote antioxidant enzyme activity and reduce oxidative stress and inflammation after surgery, 41 people with liver cancer took a placebo or 300 mg of CoQ10 per day.

Twelve weeks after surgery, CoQ10 levels had increased five times more for CoQ10 compared to placebo. Oxidative stress levels decreased in the CoQ10 group while increasing for placebo. Levels of the inflammatory molecule, C-reactive protein, decreased a similar amount in both groups. Interleukin-6 levels in the CoQ10 group were half that of placebo. The CoQ10 group also had greater increases in antioxidant capacity, especially the important antioxidant, superoxide dismutase (SOD).


Previous Next Back to Top
More Related Articles